ARG1 and glioblastoma: A selective Arginase-1 inhibitor, nor-NOHA reversed growth-promoting effects of arginase-1 carried by TAM-derived exosomes, suggesting that GBex-reprogrammed Arginase-1+ TAMs emerge as a major source of exosomes promoting tumor growth and as a potential therapeutic target in glioblastoma (128).